EQ-5D-5L utilities per health states in Spanish population with knee or hip osteoarthritis
- PMID: 31666071
- PMCID: PMC6822337
- DOI: 10.1186/s12955-019-1230-x
EQ-5D-5L utilities per health states in Spanish population with knee or hip osteoarthritis
Abstract
Background: The objective of this study was to obtain utilities by means of EQ-5D-5L for different health states in patients with knee osteoarthritis (KOA) or hip osteoarthritis (HOA) in Spain, and to compare these values with those used in foreign studies with the aim of discussing their transferability for their use in economic evaluations conducted in Spain.
Methods: Primary study: Observational prospective study of KOA or HOA patients in Spain. Sociodemographic and clinical characteristics were collected to characterize the sample. Utilities were elicited using the EQ-5D-5L questionnaire. ANOVA and bivariable analyses were conducted to identify differences between health states.
Literature review: Using the bibliographic databases NSH EED and CEA Registry, we conducted searches of model-based cost utilities analyses of technologies in KOA or HOA patients. Health states and utilities were extracted and compared with values obtained from the Spanish sample.
Results: Three hundred ninety-seven subjects with KOA and 361 subjects with HOA were included, with average utilities of 0.544 and 0.520, respectively. In both samples, differences were found in utilities according to level of pain, stiffness and physical function (WOMAC) and severity of symptoms (Oxford scales), so that the worst the symptoms, the lower the utilities. The utilities after surgery were higher than before surgery. Due to limitations from our study related to sample size and observational design, it was not possible to estimate utilities for approximately half the health states included in the published models because they were directly related to specific technologies. For almost 100% of health states of the selected studies we obtained very different utilities from those reported in the literature.
Conclusions: To our knowledge this is the first article with detailed utilities estimated using the EQ-5D-5L in Spain for KOA and HOA patients. In both populations, utilities are lower for worse health states in terms of level of pain, stiffness and physical function according to WOMAC, and according to the Oxford scales. Most utilities obtained from the Spanish sample are lower than those reported in the international literature. Further studies estimating utilities from local populations are required to avoid the use of foreign sources in economic evaluations.
Keywords: EQ-5D-5L; Health states; Hip osteoarthritis; Knee osteoarthritis; Utilities.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis.Health Qual Life Outcomes. 2020 Jun 15;18(1):184. doi: 10.1186/s12955-020-01435-8. Health Qual Life Outcomes. 2020. PMID: 32539838 Free PMC article.
-
Mapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis.Value Health. 2020 Mar;23(3):379-387. doi: 10.1016/j.jval.2019.09.2755. Epub 2019 Nov 8. Value Health. 2020. PMID: 32197734
-
Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.Qual Life Res. 2018 Nov;27(11):2897-2908. doi: 10.1007/s11136-018-1929-x. Epub 2018 Jul 5. Qual Life Res. 2018. PMID: 29978346
-
Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain.Health Qual Life Outcomes. 2013 Jul 1;11:110. doi: 10.1186/1477-7525-11-110. Health Qual Life Outcomes. 2013. PMID: 23815777 Free PMC article. Review.
-
Impact of Choice of Tariff When Calculating Clinically Meaningful EQ-5D Scores in Metabolic Dysfunction-Associated Steatohepatitis.Liver Int. 2025 May;45(5):e70043. doi: 10.1111/liv.70043. Liver Int. 2025. PMID: 40192123 Free PMC article.
Cited by
-
Early Cost-Effectiveness Analysis of Intra-articular Delivery of a PBAE-DEX Conjugate for Osteoarthritis in a UK Population.Clin Drug Investig. 2025 Jul;45(7):387-399. doi: 10.1007/s40261-025-01446-7. Epub 2025 Apr 30. Clin Drug Investig. 2025. PMID: 40304999
-
The impact of pain on quality of life in patients with osteoarthritis: a cross-sectional study from Palestine.BMC Musculoskelet Disord. 2022 Mar 14;23(1):248. doi: 10.1186/s12891-022-05207-x. BMC Musculoskelet Disord. 2022. PMID: 35287651 Free PMC article.
-
Comparison of the EQ-5D-3L and EQ-5D-5L instruments in patients undergoing unicompartmental knee arthroplasty.Front Med (Lausanne). 2025 Jan 6;11:1451979. doi: 10.3389/fmed.2024.1451979. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39835100 Free PMC article.
-
Impact of lower limb osteoarthritis on health-related quality of life: A cross-sectional study to estimate the expressed loss of utility in the Spanish population.PLoS One. 2020 Jan 24;15(1):e0228398. doi: 10.1371/journal.pone.0228398. eCollection 2020. PLoS One. 2020. PMID: 31978194 Free PMC article.
-
Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan.Pharmacoecon Open. 2022 Jan;6(1):33-45. doi: 10.1007/s41669-021-00292-5. Epub 2021 Aug 10. Pharmacoecon Open. 2022. PMID: 34374962 Free PMC article.
References
-
- Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartil. 2011;19:1270–85. - PubMed
-
- Xie F, Kovic B, Jin X, He X, Wang M, Silvestre C. Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. Pharmacoeconomics. 2016;34:1087–100. - PubMed
-
- van der Waal JM, Terwee CB, van der Windt DAWM, Bouter LM, Dekker J. The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review. Qual Life Res. 2005;14:1141–55. - PubMed
-
- Puig-Junoy J, Ruiz ZA. Socio-economic costs of osteoarthritis: a systematic review of cost-of-illness studies. Semin Arthritis Rheum. 2015;44:531–41. - PubMed
-
- Loza E, Lopez-Gomez JM, Abasolo L, Maese J, Carmona L, Batlle-Gualda E, et al. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 2009;61:158–65. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources